Florida 2022 Regular Session

Florida House Bill H1323 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3	HB 1323 2022
4	4
5	5
6	6
7	7	CODING: Words stricken are deletions; words underlined are additions.
8	8	hb1323-00
9	9	Page 1 of 40
10	10	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
11	11
12	12
13	13
14	14	A bill to be entitled 1
15	15	An act relating to pharmaceutical products containing 2
16	16	cannabis; amending s. 893.03, F.S.; excluding cannabis 3
17	17	from Schedule I listing if it is contained within a 4
18	18	pharmaceutical product approved by the United States 5
19	19	Food and Drug Administration; providing construction; 6
20	20	providing an effective date. 7
21	21	8
22	22	Be It Enacted by the Legislature of the State of Florida: 9
23	23	10
24	24	Section 1. Paragraph (c) of subsection (1) of sectio n 11
25	25	893.03, Florida Statutes, is amended to read: 12
26	26	893.03 Standards and schedules. —The substances enumerated 13
27	27	in this section are controlled by this chapter. The controlled 14
28	28	substances listed or to be listed in Schedules I, II, III, IV, 15
29	29	and V are included by whatever official, common, usual, 16
30	30	chemical, trade name, or class designated. The provisions of 17
31	31	this section shall not be construed to include within any of the 18
32	32	schedules contained in this section any excluded drugs listed 19
33	33	within the purview of 21 C.F.R. s. 1308.22, styled "Excluded 20
34	34	Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical 21
35	35	Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted 22
36	36	Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt 23
37	37	Anabolic Steroid Products." 24
38	38	(1) SCHEDULE I.—A substance in Schedule I has a high 25
39	39
40	40	HB 1323 2022
41	41
42	42
43	43
44	44	CODING: Words stricken are deletions; words underlined are additions.
45	45	hb1323-00
46	46	Page 2 of 40
47	47	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
48	48
49	49
50	50
51	51	potential for abuse and has no currently accepted medical use in 26
52	52	treatment in the United States and in its use under medical 27
53	53	supervision does not meet accepted safety standards. The 28
54	54	following substances are controlled in Sche dule I: 29
55	55	(c) Unless specifically excepted or unless listed in 30
56	56	another schedule, any material, compound, mixture, or 31
57	57	preparation that contains any quantity of the following 32
58	58	hallucinogenic substances or that contains any of their salts, 33
59	59	isomers, including o ptical, positional, or geometric isomers, 34
60	60	homologues, nitrogen -heterocyclic analogs, esters, ethers, and 35
61	61	salts of isomers, homologues, nitrogen -heterocyclic analogs, 36
62	62	esters, or ethers, if the existence of such salts, isomers, and 37
63	63	salts of isomers is possib le within the specific chemical 38
64	64	designation or class description: 39
65	65	1. Alpha-Ethyltryptamine. 40
66	66	2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-41
67	67	oxazoline). 42
68	68	3. Aminorex (2-Amino-5-phenyl-2-oxazoline). 43
69	69	4. DOB (4-Bromo-2,5-dimethoxyamphetamine). 44
70	70	5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 45
71	71	6. Bufotenine. 46
72	72	7. Cannabis, except if it is contained within a 47
73	73	pharmaceutical product approved by the United States Food and 48
74	74	Drug Administration. 49
75	75	8. Cathinone. 50
76	76
77	77	HB 1323 2022
78	78
79	79
80	80
81	81	CODING: Words stricken are deletions; words underlined are additions.
82	82	hb1323-00
83	83	Page 3 of 40
84	84	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
85	85
86	86
87	87
88	88	9. DET (Diethyltryptamine). 51
89	89	10. 2,5-Dimethoxyamphetamine. 52
90	90	11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine). 53
91	91	12. DMT (Dimethyltryptamine). 54
92	92	13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine 55
93	93	analog of phencyclidine). 56
94	94	14. JB-318 (N-Ethyl-3-piperidyl benzilate). 57
95	95	15. N-Ethylamphetamine. 58
96	96	16. Fenethylline. 59
97	97	17. 3,4-Methylenedioxy-N-hydroxyamphetamine. 60
98	98	18. Ibogaine. 61
99	99	19. LSD (Lysergic acid diethylamide). 62
100	100	20. Mescaline. 63
101	101	21. Methcathinone. 64
102	102	22. 5-Methoxy-3,4-methylenedioxyamphetamine. 65
103	103	23. PMA (4-Methoxyamphetamine). 66
104	104	24. PMMA (4-Methoxymethamphetamine). 67
105	105	25. DOM (4-Methyl-2,5-dimethoxyamphetamine). 68
106	106	26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 69
107	107	27. MDA (3,4-Methylenedioxyamphetamine). 70
108	108	28. JB-336 (N-Methyl-3-piperidyl benzilate). 71
109	109	29. N,N-Dimethylamphetamine. 72
110	110	30. Parahexyl. 73
111	111	31. Peyote. 74
112	112	32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine 75
113	113
114	114	HB 1323 2022
115	115
116	116
117	117
118	118	CODING: Words stricken are deletions; words underlined are additions.
119	119	hb1323-00
120	120	Page 4 of 40
121	121	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
122	122
123	123
124	124
125	125	analog of phencyclidine). 76
126	126	33. Psilocybin. 77
127	127	34. Psilocyn. 78
128	128	35. Salvia divinorum, except for any drug product approved 79
129	129	by the United States Food and Drug Administration which contains 80
130	130	Salvia divinorum or its isomers, esters, ethers, salts, and 81
131	131	salts of isomers, esters, and ethers, if the existence of such 82
132	132	isomers, esters, ethers, and salts is possible within the 83
133	133	specific chemical designation. 84
134	134	36. Salvinorin A, except for any drug product approved by 85
135	135	the United States Food and Drug Administration which contains 86
136	136	Salvinorin A or its isomers, esters, ethers, salts, and salts of 87
137	137	isomers, esters, and ethers, if the existence of such isomers, 88
138	138	esters, ethers, and salts is possible within the specific 89
139	139	chemical designation. 90
140	140	37. Xylazine. 91
141	141	38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine) 92
142	142	(Thiophene analog of phencyclidine). 93
143	143	39. 3,4,5-Trimethoxyamphetamine. 94
144	144	40. Methylone (3,4-Methylenedioxymethcathinone). 95
145	145	41. MDPV (3,4-Methylenedioxypyrovalerone). 96
146	146	42. Methylmethcathinone. 97
147	147	43. Methoxymethcathinone. 98
148	148	44. Fluoromethcathinone. 99
149	149	45. Methylethcathinone. 100
150	150
151	151	HB 1323 2022
152	152
153	153
154	154
155	155	CODING: Words stricken are deletions; words underlined are additions.
156	156	hb1323-00
157	157	Page 5 of 40
158	158	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
159	159
160	160
161	161
162	162	46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-101
163	163	yl)phenol) and its dimethyloctyl (C8) homologue. 102
164	164	47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-103
165	165	(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-104
166	166	ol]. 105
167	167	48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 106
168	168	49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 107
169	169	50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-108
170	170	naphthoyl)indole). 109
171	171	51. BZP (Benzylpiperazine). 110
172	172	52. Fluorophenylpiperazine. 111
173	173	53. Methylphenylpiperazine. 112
174	174	54. Chlorophenylpiperazine. 113
175	175	55. Methoxyphenylpiperazine. 114
176	176	56. DBZP (1,4-Dibenzylpiperazine). 115
177	177	57. TFMPP (Trifluoromethylphenylpiperazine). 116
178	178	58. MBDB (Methylbenzodioxolylbutanamine) or (3,4 -117
179	179	Methylenedioxy-N-methylbutanamine). 118
180	180	59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 119
181	181	60. 5-Hydroxy-N-methyltryptamine. 120
182	182	61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 121
183	183	62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 122
184	184	63. Methyltryptamine. 123
185	185	64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 124
186	186	65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 125
187	187
188	188	HB 1323 2022
189	189
190	190
191	191
192	192	CODING: Words stricken are deletions; words underlined are additions.
193	193	hb1323-00
194	194	Page 6 of 40
195	195	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
196	196
197	197
198	198
199	199	66. Tyramine (4-Hydroxyphenethylamine). 126
200	200	67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 127
201	201	68. DiPT (N,N-Diisopropyltryptamine). 128
202	202	69. DPT (N,N-Dipropyltryptamine). 129
203	203	70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 130
204	204	71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 131
205	205	72. DOI (4-Iodo-2,5-dimethoxyamphetamine). 132
206	206	73. DOC (4-Chloro-2,5-dimethoxyamphetamine). 133
207	207	74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 134
208	208	75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 135
209	209	76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 136
210	210	77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 137
211	211	78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 138
212	212	79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 139
213	213	80. 2C-I (4-Iodo-2,5-dimethoxyphenethylami ne). 140
214	214	81. Butylone (3,4-Methylenedioxy-alpha-141
215	215	methylaminobutyrophenone). 142
216	216	82. Ethcathinone. 143
217	217	83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 144
218	218	84. Naphyrone (Naphthylpyrovalerone). 145
219	219	85. Dimethylone (3,4 -Methylenedioxy-N,N-146
220	220	dimethylcathinone). 147
221	221	86. 3,4-Methylenedioxy-N,N-diethylcathinone. 148
222	222	87. 3,4-Methylenedioxy-propiophenone. 149
223	223	88. 3,4-Methylenedioxy-alpha-bromopropiophenone. 150
224	224
225	225	HB 1323 2022
226	226
227	227
228	228
229	229	CODING: Words stricken are deletions; words underlined are additions.
230	230	hb1323-00
231	231	Page 7 of 40
232	232	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
233	233
234	234
235	235
236	236	89. 3,4-Methylenedioxy-propiophenone-2-oxime. 151
237	237	90. 3,4-Methylenedioxy-N-acetylcathinone. 152
238	238	91. 3,4-Methylenedioxy-N-acetylmethcathinone. 153
239	239	92. 3,4-Methylenedioxy-N-acetylethcathinone. 154
240	240	93. Bromomethcathinone. 155
241	241	94. Buphedrone (alpha -Methylamino-butyrophenone). 156
242	242	95. Eutylone (3,4-Methylenedioxy-alpha-157
243	243	ethylaminobutyrophenone). 158
244	244	96. Dimethylcathinone. 159
245	245	97. Dimethylmethcathinone. 160
246	246	98. Pentylone (3,4-Methylenedioxy-alpha-161
247	247	methylaminovalerophenone). 162
248	248	99. MDPPP (3,4-Methylenedioxy-alpha-163
249	249	pyrrolidinopropiophenone). 164
250	250	100. MDPBP (3,4-Methylenedioxy-alpha-165
251	251	pyrrolidinobutyrophenone). 166
252	252	101. MOPPP (Methoxy -alpha-pyrrolidinopropiophenone). 167
253	253	102. MPHP (Methyl-alpha-pyrrolidinohexanophenone). 168
254	254	103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 169
255	255	(Benocyclidine). 170
256	256	104. F-MABP (Fluoromethylaminobutyrophenone). 171
257	257	105. MeO-PBP (Methoxypyrrolidinobutyrophenone). 172
258	258	106. Et-PBP (Ethylpyrrolidinobutyrophenone). 173
259	259	107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 174
260	260	108. Me-EABP (Methylethylaminobutyrophenone). 175
261	261
262	262	HB 1323 2022
263	263
264	264
265	265
266	266	CODING: Words stricken are deletions; words underlined are additions.
267	267	hb1323-00
268	268	Page 8 of 40
269	269	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
270	270
271	271
272	272
273	273	109. Etizolam. 176
274	274	110. PPP (Pyrrolidinopropiophenone). 177
275	275	111. PBP (Pyrrolidinobutyrophenone). 178
276	276	112. PVP (Pyrrolidinovalerophenone) or 179
277	277	(Pyrrolidinopentiophenone). 180
278	278	113. MPPP (Methyl-alpha-pyrrolidinopropiophenone). 181
279	279	114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 182
280	280	115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 183
281	281	116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 184
282	282	117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 185
283	283	118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 186
284	284	119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 187
285	285	120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 188
286	286	121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-189
287	287	methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 190
288	288	122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 191
289	289	123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 192
290	290	124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 193
291	291	125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 194
292	292	126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 195
293	293	127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 196
294	294	128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 197
295	295	129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole). 198
296	296	130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-199
297	297	(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-200
298	298
299	299	HB 1323 2022
300	300
301	301
302	302
303	303	CODING: Words stricken are deletions; words underlined are additions.
304	304	hb1323-00
305	305	Page 9 of 40
306	306	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
307	307
308	308
309	309
310	310	ol). 201
311	311	131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-202
312	312	methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-203
313	313	enyl] methanol). 204
314	314	132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-205
315	315	methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-206
316	316	1,4-dione). 207
317	317	133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene). 208
318	318	134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-209
319	319	undecanamide). 210
320	320	135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-211
321	321	undecanamide). 212
322	322	136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-213
323	323	methyloctan-2-yl)phenol). 214
324	324	137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 215
325	325	138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole). 216
326	326	139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 217
327	327	140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-218
328	328	methoxyphenylacetyl)indole). 219
329	329	141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-220
330	330	morpholinylmethyl)pyrrolo[1,2,3 -de]-1,4-benzoxazin-6-yl]-1-221
331	331	naphthalenylmethanone). 222
332	332	142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-223
333	333	morpholinylmethyl)pyrrolo[1,2,3 -de]-1,4-benzoxazin-6-yl]-1-224
334	334	naphthalenylmethanone). 225
335	335
336	336	HB 1323 2022
337	337
338	338
339	339
340	340	CODING: Words stricken are deletions; words underlined are additions.
341	341	hb1323-00
342	342	Page 10 of 40
343	343	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
344	344
345	345
346	346
347	347	143. Pentedrone (alpha -Methylaminovalerophenone). 226
348	348	144. Fluoroamphetamine. 227
349	349	145. Fluoromethamphetamine. 228
350	350	146. Methoxetamine. 229
351	351	147. Methiopropamine. 230
352	352	148. Methylbuphedrone (Methyl -alpha-231
353	353	methylaminobutyrophenone). 232
354	354	149. APB ((2-Aminopropyl)benzofuran). 233
355	355	150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran). 234
356	356	151. UR-144 (1-Pentyl-3-(2,2,3,3-235
357	357	tetramethylcyclopropanoyl)indole). 236
358	358	152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-237
359	359	tetramethylcyclopropanoyl)indole). 238
360	360	153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-239
361	361	tetramethylcyclopropanoyl)indole). 240
362	362	154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-241
363	363	carboxamide). 242
364	364	155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-243
365	365	iodobenzoyl)indole). 244
366	366	156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-245
367	367	carboxamide). 246
368	368	157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-247
369	369	cyclohexylcarbamate). 248
370	370	158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid, 249
371	371	cyclohexyl ester). 250
372	372
373	373	HB 1323 2022
374	374
375	375
376	376
377	377	CODING: Words stricken are deletions; words underlined are additions.
378	378	hb1323-00
379	379	Page 11 of 40
380	380	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
381	381
382	382
383	383
384	384	159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-251
385	385	benzoxazin-4-one). 252
386	386	160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 253
387	387	161. 2C-H (2,5-Dimethoxyphenethylamine). 254
388	388	162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 255
389	389	163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 256
390	390	164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-257
391	391	methoxybenzyl)]phenethylamine). 258
392	392	165. MDMA (3,4-Methylenedioxymethamp hetamine). 259
393	393	166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 260
394	394	167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole -3-261
395	395	carboxylate). 262
396	396	168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole -3-263
397	397	carboxylate). 264
398	398	169. Fluoro AKB48 (N -Adamant-1-yl 1-265
399	399	(fluoropentyl)indazole-3-carboxamide). 266
400	400	170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-267
401	401	pentylindazole-3-carboxamide). 268
402	402	171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-269
403	403	(4-fluorobenzyl)indazole -3-carboxamide). 270
404	404	172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-271
405	405	1-pentylindazole-3-carboxamide). 272
406	406	173. Fluoro ADBICA (N -(1-Amino-3,3-dimethyl-1-oxobutan-2-273
407	407	yl)-1-(fluoropentyl)indole -3-carboxamide). 274
408	408	174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-275
409	409
410	410	HB 1323 2022
411	411
412	412
413	413
414	414	CODING: Words stricken are deletions; words underlined are additions.
415	415	hb1323-00
416	416	Page 12 of 40
417	417	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
418	418
419	419
420	420
421	421	methoxybenzyl)]phenethylamine). 276
422	422	175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-277
423	423	methoxybenzyl)]phenethylamine). 278
424	424	176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-279
425	425	(cyclohexylmethyl)indazole -3-carboxamide). 280
426	426	177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-281
427	427	carboxylate). 282
428	428	178. Fluoro-NNEI (N-Naphthalen-1-yl 1-283
429	429	(fluoropentyl)indole -3-carboxamide). 284
430	430	179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-285
431	431	(fluoropentyl)indazole -3-carboxamide). 286
432	432	180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-287
433	433	naphthoyl)indazole). 288
434	434	181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-289
435	435	1,4,4a,8,9,10,11,12b -octahydronaphtho[3,2 -c]isochromen-12-ol). 290
436	436	182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-291
437	437	(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-292
438	438	hexahydrobenzo[c]chromen -1-ol). 293
439	439	183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-294
440	440	(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-295
441	441	hexahydrobenzo[c]chromen -1-ol). 296
442	442	184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-297
443	443	6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 298
444	444	diol). 299
445	445	185. HU-243 ((6aR,8S,9S,10aR) -9-(Hydroxymethyl)-6,6-300
446	446
447	447	HB 1323 2022
448	448
449	449
450	450
451	451	CODING: Words stricken are deletions; words underlined are additions.
452	452	hb1323-00
453	453	Page 13 of 40
454	454	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
455	455
456	456
457	457
458	458	dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-301
459	459	tetrahydro-6aH-benzo[c]chromen-1-ol). 302
460	460	186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-303
461	461	6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione). 304
462	462	187. MAPB ((2-Methylaminopropyl)benzofuran). 305
463	463	188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine). 306
464	464	189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine). 307
465	465	190. Synthetic Cannabinoids. —Unless specifically excepted 308
466	466	or unless listed in another schedule or contained within a 309
467	467	pharmaceutical product approved by the United States Food and 310
468	468	Drug Administration, any material, compound, mixture, or 311
469	469	preparation that contains any quantity of a synthetic 312
470	470	cannabinoid found to be in any of the following chemical class 313
471	471	descriptions, or homologues, nitrogen -heterocyclic analogs, 314
472	472	isomers (including optical, positional, or geometric), esters, 315
473	473	ethers, salts, and salts of homologues, nitrogen -heterocyclic 316
474	474	analogs, isomers, esters, or ethers, whenever the existence of 317
475	475	such homologues, nitrogen -heterocyclic analogs, isomers, esters, 318
476	476	ethers, salts, and salts of isomers, esters, or ethers is 319
477	477	possible within the specific chemical class or designation. 320
478	478	Since nomenclature of these synthetically produced cannabinoids 321
479	479	is not internationally standardized and may continuall y evolve, 322
480	480	these structures or the compounds of these structures shall be 323
481	481	included under this subparagraph, regardless of their specific 324
482	482	numerical designation of atomic positions covered, if it can be 325
483	483
484	484	HB 1323 2022
485	485
486	486
487	487
488	488	CODING: Words stricken are deletions; words underlined are additions.
489	489	hb1323-00
490	490	Page 14 of 40
491	491	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
492	492
493	493
494	494
495	495	determined through a recognized method of scientific tes ting or 326
496	496	analysis that the substance contains properties that fit within 327
497	497	one or more of the following categories: 328
498	498	a. Tetrahydrocannabinols. —Any tetrahydrocannabinols 329
499	499	naturally contained in a plant of the genus Cannabis, the 330
500	500	synthetic equivalents of the su bstances contained in the plant 331
501	501	or in the resinous extracts of the genus Cannabis, or synthetic 332
502	502	substances, derivatives, and their isomers with similar chemical 333
503	503	structure and pharmacological activity, including, but not 334
504	504	limited to, Delta 9 tetrahydrocannab inols and their optical 335
505	505	isomers, Delta 8 tetrahydrocannabinols and their optical 336
506	506	isomers, Delta 6a,10a tetrahydrocannabinols and their optical 337
507	507	isomers, or any compound containing a tetrahydrobenzo[c]chromene 338
508	508	structure with substitution at either or both th e 3-position or 339
509	509	9-position, with or without substitution at the 1 -position with 340
510	510	hydroxyl or alkoxy groups, including, but not limited to: 341
511	511	(I) Tetrahydrocannabinol. 342
512	512	(II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-343
513	513	(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-344
514	514	ol). 345
515	515	(III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-346
516	516	(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-347
517	517	ol). 348
518	518	(IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-349
519	519	(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 350
520	520
521	521	HB 1323 2022
522	522
523	523
524	524
525	525	CODING: Words stricken are deletions; words underlined are additions.
526	526	hb1323-00
527	527	Page 15 of 40
528	528	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
529	529
530	530
531	531
532	532	(V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-351
533	533	2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 352
534	534	(VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-353
535	535	2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 354
536	536	(VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-355
537	537	(2,3-dimethylpentan-2-yl)-6a,7,10,10a-356
538	538	tetrahydrobenzo[c]chromene). 357
539	539	(VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-358
540	540	6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-ol). 359
541	541	(IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-360
542	542	6a,7,10,10a-tetrahydrobenzo[c]chromen -1-ol). 361
543	543	(X) Parahexyl. 362
544	544	b. Naphthoylindoles, Naphthoylindazoles, 363
545	545	Naphthoylcarbazoles, Naphthylmethylindoles, 364
546	546	Naphthylmethylindazoles, and Naphthylmethylcarbazoles. —Any 365
547	547	compound containing a naphthoylindole, naphthoylindazole, 366
548	548	naphthoylcarbazole, naphthylmethylindole, 367
549	549	naphthylmethylindazole, or naphthylmethylcarbazole structure, 368
550	550	with or without substitution on the indole, indazole, or 369
551	551	carbazole ring to any extent, whether or not substituted on the 370
552	552	naphthyl ring to any extent, including, but not limited to: 371
553	553	(I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 372
554	554	(II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-373
555	555	naphthoyl)indole). 374
556	556	(III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 375
557	557
558	558	HB 1323 2022
559	559
560	560
561	561
562	562	CODING: Words stricken are deletions; words underlined are additions.
563	563	hb1323-00
564	564	Page 16 of 40
565	565	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
566	566
567	567
568	568
569	569	(IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole). 376
570	570	(V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 377
571	571	(VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 378
572	572	(VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 379
573	573	(VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole). 380
574	574	(IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole). 381
575	575	(X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 382
576	576	(XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 383
577	577	(XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole). 384
578	578	(XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 385
579	579	(XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-386
580	580	naphthoyl)indole). 387
581	581	(XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole). 388
582	582	(XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 389
583	583	(XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-390
584	584	naphthoyl)indole). 391
585	585	(XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-392
586	586	naphthoyl)indole). 393
587	587	(XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 394
588	588	(XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole). 395
589	589	(XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole). 396
590	590	(XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-397
591	591	naphthylmethyl]indole). 398
592	592	(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-399
593	593	naphthoyl)indole). 400
594	594
595	595	HB 1323 2022
596	596
597	597
598	598
599	599	CODING: Words stricken are deletions; words underlined are additions.
600	600	hb1323-00
601	601	Page 17 of 40
602	602	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
603	603
604	604
605	605
606	606	(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-401
607	607	naphthoyl)indole). 402
608	608	(XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-403
609	609	naphthoyl)indole). 404
610	610	(XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 405
611	611	(XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole). 406
612	612	(XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-407
613	613	naphthoyl)indole). 408
614	614	(XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole). 409
615	615	(XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole). 410
616	616	(XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-411
617	617	naphthoyl)indole). 412
618	618	(XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-413
619	619	naphthoyl)indole). 414
620	620	(XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-415
621	621	naphthoyl)indole). 416
622	622	(XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-417
623	623	naphthoyl)indole). 418
624	624	(XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-419
625	625	naphthoyl)indole). 420
626	626	(XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole). 421
627	627	(XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-422
628	628	naphthoyl)indazole). 423
629	629	(XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-424
630	630	naphthoyl)indole). 425
631	631
632	632	HB 1323 2022
633	633
634	634
635	635
636	636	CODING: Words stricken are deletions; words underlined are additions.
637	637	hb1323-00
638	638	Page 18 of 40
639	639	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
640	640
641	641
642	642
643	643	(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-426
644	644	naphthoyl)indole). 427
645	645	(XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole). 428
646	646	(XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-429
647	647	naphthoyl)carbazole). 430
648	648	c. Naphthoylpyrroles. —Any compound containing a 431
649	649	naphthoylpyrrole structure, with or without substitution on the 432
650	650	pyrrole ring to any extent, whether or not substituted on the 433
651	651	naphthyl ring to any e xtent, including, but not limited to: 434
652	652	(I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole). 435
653	653	(II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole). 436
654	654	(III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole). 437
655	655	(IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole). 438
656	656	(V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole). 439
657	657	(VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-440
658	658	naphthoyl)pyrrole). 441
659	659	(VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-442
660	660	naphthoyl)pyrrole). 443
661	661	(VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-444
662	662	naphthoyl)pyrrole). 445
663	663	(IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-446
664	664	naphthoyl)pyrrole). 447
665	665	(X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-448
666	666	naphthoyl)pyrrole). 449
667	667	d. Naphthylmethylenindenes. —Any compound containing a 450
668	668
669	669	HB 1323 2022
670	670
671	671
672	672
673	673	CODING: Words stricken are deletions; words underlined are additions.
674	674	hb1323-00
675	675	Page 19 of 40
676	676	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
677	677
678	678
679	679
680	680	naphthylmethylenindene structure, with or without sub stitution 451
681	681	at the 3-position of the indene ring to any extent, whether or 452
682	682	not substituted on the naphthyl ring to any extent, including, 453
683	683	but not limited to, JWH -176 (3-Pentyl-1-454
684	684	(naphthylmethylene)indene). 455
685	685	e. Phenylacetylindoles and Phenylacetylindazoles. —Any 456
686	686	compound containing a phenylacetylindole or phenylacetylindazole 457
687	687	structure, with or without substitution on the indole or 458
688	688	indazole ring to any extent, whether or not substituted on the 459
689	689	phenyl ring to any extent, including, but not limited to: 460
690	690	(I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole). 461
691	691	(II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 462
692	692	(III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 463
693	693	(IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 464
694	694	(V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 465
695	695	(VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 466
696	696	(VII) Cannabipiperidiethanone. 467
697	697	(VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-468
698	698	methoxyphenylacetyl)indole). 469
699	699	f. Cyclohexylphenols. —Any compound containing a 470
700	700	cyclohexylphenol structure, with or without substitution at the 471
701	701	5-position of the phenolic ring to any extent, whether or not 472
702	702	substituted on the cyclohexyl ring to any extent, including, but 473
703	703	not limited to: 474
704	704	(I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-475
705	705
706	706	HB 1323 2022
707	707
708	708
709	709
710	710	CODING: Words stricken are deletions; words underlined are additions.
711	711	hb1323-00
712	712	Page 20 of 40
713	713	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
714	714
715	715
716	716
717	717	yl)phenol). 476
718	718	(II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8) 477
719	719	homologue). 478
720	720	(III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-479
721	721	methyloctan-2-yl)phenol). 480
722	722	g. Benzoylindoles and Benzoylindazoles. —Any compound 481
723	723	containing a benzoylin dole or benzoylindazole structure, with or 482
724	724	without substitution on the indole or indazole ring to any 483
725	725	extent, whether or not substituted on the phenyl ring to any 484
726	726	extent, including, but not limited to: 485
727	727	(I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole). 486
728	728	(II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 487
729	729	(III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-488
730	730	iodo-5-nitrobenzoyl)indole). 489
731	731	(IV) Pravadoline (1 -[2-(4-Morpholinyl)ethyl]-2-methyl-3-490
732	732	(4-methoxybenzoyl)indole). 491
733	733	(V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-492
734	734	iodobenzoyl)indole). 493
735	735	(VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 494
736	736	(VII) RCS-4 C4 homologue (1-Butyl-3-(4-495
737	737	methoxybenzoyl)indole). 496
738	738	(VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-497
739	739	3-(4-methoxybenzoyl)indole). 498
740	740	h. Tetramethylcyclopropanoylindoles and 499
741	741	Tetramethylcyclopropanoylindazoles. —Any compound containing a 500
742	742
743	743	HB 1323 2022
744	744
745	745
746	746
747	747	CODING: Words stricken are deletions; words underlined are additions.
748	748	hb1323-00
749	749	Page 21 of 40
750	750	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
751	751
752	752
753	753
754	754	tetramethylcyclopropanoylindole or 501
755	755	tetramethylcyclopropanoylindazole structure, with or without 502
756	756	substitution on the indole or indazole ring to any extent, 503
757	757	whether or not substituted on the tetramethylcyclopropyl group 504
758	758	to any extent, including, but not limited to: 505
759	759	(I) UR-144 (1-Pentyl-3-(2,2,3,3-506
760	760	tetramethylcyclopropanoyl)indole). 507
761	761	(II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-508
762	762	tetramethylcyclopropanoyl)indole). 509
763	763	(III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-510
764	764	tetramethylcyclopropanoyl)indole). 511
765	765	(IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-512
766	766	tetramethylcyclopropanoyl)indole). 513
767	767	(V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl] -3-(2,2,3,3-514
768	768	tetramethylcyclopropanoyl)indole). 515
769	769	(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-516
770	770	tetramethylcyclopropanoyl)indole). 517
771	771	(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-518
772	772	tetramethylcyclopropanoyl)indole). 519
773	773	(VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-520
774	774	tetramethylcyclopropan oyl)indazole). 521
775	775	(IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-522
776	776	tetramethylcyclopropanoyl)indole). 523
777	777	(X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-524
778	778	tetramethylcyclopropanoyl)indole). 525
779	779
780	780	HB 1323 2022
781	781
782	782
783	783
784	784	CODING: Words stricken are deletions; words underlined are additions.
785	785	hb1323-00
786	786	Page 22 of 40
787	787	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
788	788
789	789
790	790
791	791	i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole 526
792	792	carboxamides, and Adamantylindazole carboxamides. —Any compound 527
793	793	containing an adamantoyl indole, adamantoyl indazole, adamantyl 528
794	794	indole carboxamide, or adamantyl indazole carboxamide structure, 529
795	795	with or without substitution on the indole or indazole ring to 530
796	796	any extent, whether or not substituted on the adamantyl ring to 531
797	797	any extent, including, but not limited to: 532
798	798	(I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide). 533
799	799	(II) Fluoro AKB48 (N -Adamant-1-yl 1-534
800	800	(fluoropentyl)indazole -3-carboxamide). 535
801	801	(III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-536
802	802	carboxamide). 537
803	803	(IV) AM-1248 (1-(1-Methylpiperidine)methyl -3-(1-538
804	804	adamantoyl)indole). 539
805	805	(V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole). 540
806	806	(VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide). 541
807	807	(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-542
808	808	adamantoyl)indole). 543
809	809	j. Quinolinylindolecarboxylates, 544
810	810	Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, 545
811	811	and Quinolinylindazolecarboxamides. —Any compound containing a 546
812	812	quinolinylindole carboxylate, quinolinylindazole carboxylate, 547
813	813	isoquinolinylindole carboxylate, isoquinolinylindazole 548
814	814	carboxylate, quinolinylindole carboxamide, quinolinylindazole 549
815	815	carboxamide, isoquinolinylindole carboxamide, or 550
816	816
817	817	HB 1323 2022
818	818
819	819
820	820
821	821	CODING: Words stricken are deletions; words underlined are additions.
822	822	hb1323-00
823	823	Page 23 of 40
824	824	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
825	825
826	826
827	827
828	828	isoquinolinylindazole carboxamide structure, with or without 551
829	829	substitution on the indole or indazole ring to any extent, 552
830	830	whether or not substituted on the quinoline or isoquinoline ring 553
831	831	to any extent, including, but not limited to: 554
832	832	(I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 555
833	833	(II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-556
834	834	carboxylate). 557
835	835	(III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole -3-558
836	836	carboxylate). 559
837	837	(IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-560
838	838	carboxylate). 561
839	839	(V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate). 562
840	840	(VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole -563
841	841	3-carboxylate). 564
842	842	(VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole -565
843	843	3-carboxylate). 566
844	844	(VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide). 567
845	845	(IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole -3-568
846	846	carboxamide). 569
847	847	k. Naphthylindolecarboxylates and 570
848	848	Naphthylindazolecarboxylates. —Any compound containing a 571
849	849	naphthylindole carboxylate or naphthylindazole carboxylate 572
850	850	structure, with or without substitution on the indole or 573
851	851	indazole ring to any extent, whether or not substituted on the 574
852	852	naphthyl ring to any extent, including, but not limited to: 575
853	853
854	854	HB 1323 2022
855	855
856	856
857	857
858	858	CODING: Words stricken are deletions; words underlined are additions.
859	859	hb1323-00
860	860	Page 24 of 40
861	861	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
862	862
863	863
864	864
865	865	(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-576
866	866	carboxylate). 577
867	867	(II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-578
868	868	carboxylate). 579
869	869	(III) Fluoro SDB-005 (1-Naphthalenyl 1-580
870	870	(fluoropentyl)indazole -3-carboxylate). 581
871	871	(IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-582
872	872	carboxylate). 583
873	873	(V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole -3-584
874	874	carboxylate). 585
875	875	l. Naphthylindole carboxamides and Naphthylindazole 586
876	876	carboxamides.—Any compound containing a naphthylindole 587
877	877	carboxamide or naphthylindazole carboxamide structure, with or 588
878	878	without substitution on the indole or indazole ring to any 589
879	879	extent, whether or not substituted on the naphthyl ring to any 590
880	880	extent, including, but not limit ed to: 591
881	881	(I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide). 592
882	882	(II) Fluoro-NNEI (N-Naphthalen-1-yl 1-593
883	883	(fluoropentyl)indole -3-carboxamide). 594
884	884	(III) Chloro-NNEI (N-Naphthalen-1-yl 1-595
885	885	(chloropentyl)indole -3-carboxamide). 596
886	886	(IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-597
887	887	carboxamide). 598
888	888	(V) Fluoro MN-18 (N-Naphthalen-1-yl 1-599
889	889	(fluoropentyl)indazole -3-carboxamide). 600
890	890
891	891	HB 1323 2022
892	892
893	893
894	894
895	895	CODING: Words stricken are deletions; words underlined are additions.
896	896	hb1323-00
897	897	Page 25 of 40
898	898	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
899	899
900	900
901	901
902	902	m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl 601
903	903	indazole carboxamides, Alkylcarbonyl indole carboxylates, and 602
904	904	Alkylcarbonyl indazole carbo xylates.—Any compound containing an 603
905	905	alkylcarbonyl group, including 1 -amino-3-methyl-1-oxobutan-2-yl, 604
906	906	1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-605
907	907	phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an 606
908	908	indole carboxamide, indazole carboxamid e, indole carboxylate, or 607
909	909	indazole carboxylate, with or without substitution on the indole 608
910	910	or indazole ring to any extent, whether or not substituted on 609
911	911	the alkylcarbonyl group to any extent, including, but not 610
912	912	limited to: 611
913	913	(I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-612
914	914	pentylindole-3-carboxamide). 613
915	915	(II) Fluoro ADBICA (N -(1-Amino-3,3-dimethyl-1-oxobutan-2-614
916	916	yl)-1-(fluoropentyl)indole -3-carboxamide). 615
917	917	(III) Fluoro ABICA (N -(1-Amino-3-methyl-1-oxobutan-2-yl)-616
918	918	1-(fluoropentyl)indole -3-carboxamide). 617
919	919	(IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-618
920	920	pentylindazole-3-carboxamide). 619
921	921	(V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-620
922	922	yl)-1-(fluoropentyl)indazole -3-carboxamide). 621
923	923	(VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-622
924	924	1-pentylindazole-3-carboxamide). 623
925	925	(VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-624
926	926	oxobutan-2-yl)-1-(fluoropentyl)indazole -3-carboxamide). 625
927	927
928	928	HB 1323 2022
929	929
930	930
931	931
932	932	CODING: Words stricken are deletions; words underlined are additions.
933	933	hb1323-00
934	934	Page 26 of 40
935	935	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
936	936
937	937
938	938
939	939	(VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-626
940	940	1-(4-fluorobenzyl)indazole -3-carboxamide). 627
941	941	(IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-628
942	942	yl)-1-(4-fluorobenzyl)indazole -3-carboxamide). 629
943	943	(X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-630
944	944	(cyclohexylmethyl)indazole -3-carboxamide). 631
945	945	(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-632
946	946	1-(cyclohexylmethyl)indazole-3-carboxamide). 633
947	947	(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-634
948	948	yl)-1-(cyclohexylmethyl)indazole -3-carboxamide). 635
949	949	(XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-636
950	950	pentylindazole-3-carboxamide). 637
951	951	(XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-638
952	952	1-(fluoropentyl)indazole -3-carboxamide). 639
953	953	(XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-640
954	954	fluorobenzyl)indazole -3-carboxamide). 641
955	955	(XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-642
956	956	2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide). 643
957	957	(XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-644
958	958	oxobutan-2-yl)-1-(4-fluorobenzyl)indazole -3-carboxamide). 645
959	959	(XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-646
960	960	2-yl)-1-(cyclohexylmethyl)indole -3-carboxamide). 647
961	961	(XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-648
962	962	fluoropentyl)indole-3-carboxamide). 649
963	963	(XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-650
964	964
965	965	HB 1323 2022
966	966
967	967
968	968
969	969	CODING: Words stricken are deletions; words underlined are additions.
970	970	hb1323-00
971	971	Page 27 of 40
972	972	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
973	973
974	974
975	975
976	976	fluoropentyl)indazole -3-carboxamide). 651
977	977	(XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-652
978	978	(cyclohexylmethyl)indazole -3-carboxamide). 653
979	979	(XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-654
980	980	fluorobenzyl)indazole -3-carboxamide). 655
981	981	(XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-656
982	982	2-yl)-1-(cyclohexylmethyl)indazole -3-carboxylate). 657
983	983	n. Cumylindolecarboxamides and Cumylindazolecarboxamides. —658
984	984	Any compound containing a N -(2-phenylpropan-2-yl) indole 659
985	985	carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide 660
986	986	structure, with or without substitution on the indole or 661
987	987	indazole ring to any extent, whether or not substituted on the 662
988	988	phenyl ring of the cumyl group to any extent, including, but not 663
989	989	limited to: 664
990	990	(I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-665
991	991	carboxamide). 666
992	992	(II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-667
993	993	(fluoropentyl)indole -3-carboxamide). 668
994	994	o. Other Synthetic Cannabinoids. —Any material, compound, 669
995	995	mixture, or preparation that contains any quantity of a 670
996	996	Synthetic Cannabinoid, as described in sub -subparagraphs a.-n.: 671
997	997	(I) With or without modification or replacement of a 672
998	998	carbonyl, carboxamide, alky lene, alkyl, or carboxylate linkage 673
999	999	between either two core rings, or linkage between a core ring 674
1000	1000	and group structure, with or without the addition of a carbon or 675
1001	1001
1002	1002	HB 1323 2022
1003	1003
1004	1004
1005	1005
1006	1006	CODING: Words stricken are deletions; words underlined are additions.
1007	1007	hb1323-00
1008	1008	Page 28 of 40
1009	1009	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1010	1010
1011	1011
1012	1012
1013	1013	replacement of a carbon; 676
1014	1014	(II) With or without replacement of a core ring or group 677
1015	1015	structure, whether or not substituted on the ring or group 678
1016	1016	structures to any extent; and 679
1017	1017	(III) Is a cannabinoid receptor agonist, unless 680
1018	1018	specifically excepted or unless listed in another schedule or 681
1019	1019	contained within a pharmaceutical product approved by the United 682
1020	1020	States Food and Drug Administration. 683
1021	1021	191. Substituted Cathinones. —Unless specifically excepted, 684
1022	1022	listed in another schedule, or contained within a pharmaceutical 685
1023	1023	product approved by the United States Food and Drug 686
1024	1024	Administration, any material, compound, mixture, or preparation, 687
1025	1025	including its salts, isomers, esters, or ethers, and salts of 688
1026	1026	isomers, esters, or ethers, whenever the existence of such salts 689
1027	1027	is possible within any of the following specific chemical 690
1028	1028	designations: 691
1029	1029	a. Any compound containing a 2 -amino-1-phenyl-1-propanone 692
1030	1030	structure; 693
1031	1031	b. Any compound containing a 2 -amino-1-naphthyl-1-694
1032	1032	propanone structure; or 695
1033	1033	c. Any compound containing a 2 -amino-1-thiophenyl-1-696
1034	1034	propanone structure, 697
1035	1035	698
1036	1036	whether or not the compound is further modified: 699
1037	1037	(I) With or without substitution on the ring system to any 700
1038	1038
1039	1039	HB 1323 2022
1040	1040
1041	1041
1042	1042
1043	1043	CODING: Words stricken are deletions; words underlined are additions.
1044	1044	hb1323-00
1045	1045	Page 29 of 40
1046	1046	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1047	1047
1048	1048
1049	1049
1050	1050	extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy, 701
1051	1051	haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused 702
1052	1052	dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide 703
1053	1053	substituents; 704
1054	1054	(II) With or without substitution at the 3 -propanone 705
1055	1055	position with an alkyl substituent or removal of the methyl 706
1056	1056	group at the 3-propanone position; 707
1057	1057	(III) With or without substitution at the 2 -amino nitrogen 708
1058	1058	atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or 709
1059	1059	not further substituted in the ring system; or 710
1060	1060	(IV) With or without inclusion of the 2 -amino nitrogen 711
1061	1061	atom in a cyclic structure, including, but not limited to: 712
1062	1062	(A) Methcathinone. 713
1063	1063	(B) Ethcathinone. 714
1064	1064	(C) Methylone (3,4-Methylenedioxymethcathinone). 715
1065	1065	(D) 2,3-Methylenedioxymethcathinone. 716
1066	1066	(E) MDPV (3,4-Methylenedioxypyrovalerone). 717
1067	1067	(F) Methylmethcathinone. 718
1068	1068	(G) Methoxymethcathinone. 719
1069	1069	(H) Fluoromethcathinone. 720
1070	1070	(I) Methylethcathinone. 721
1071	1071	(J) Butylone (3,4-Methylenedioxy-alpha-722
1072	1072	methylaminobutyrophenone). 723
1073	1073	(K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 724
1074	1074	(L) BMDP (3,4-Methylenedioxy-N-benzylcathinone). 725
1075	1075
1076	1076	HB 1323 2022
1077	1077
1078	1078
1079	1079
1080	1080	CODING: Words stricken are deletions; words underlined are additions.
1081	1081	hb1323-00
1082	1082	Page 30 of 40
1083	1083	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1084	1084
1085	1085
1086	1086
1087	1087	(M) Naphyrone (Naphthylpyrovalerone). 726
1088	1088	(N) Bromomethcathinone. 727
1089	1089	(O) Buphedrone (alpha -Methylaminobutyrophenone). 728
1090	1090	(P) Eutylone (3,4-Methylenedioxy-alpha-729
1091	1091	ethylaminobutyrophenone). 730
1092	1092	(Q) Dimethylcathinone. 731
1093	1093	(R) Dimethylmethcathinone. 732
1094	1094	(S) Pentylone (3,4-Methylenedioxy-alpha-733
1095	1095	methylaminovalerophenone). 734
1096	1096	(T) Pentedrone (alpha -Methylaminovalerophenone). 735
1097	1097	(U) MDPPP (3,4-Methylenedioxy-alpha-736
1098	1098	pyrrolidinopropiophenone). 737
1099	1099	(V) MDPBP (3,4-Methylenedioxy-alpha-738
1100	1100	pyrrolidinobutyrophenone). 739
1101	1101	(W) MPPP (Methyl-alpha-pyrrolidinopropiophenone). 740
1102	1102	(X) PPP (Pyrrolidinopropiophenone). 741
1103	1103	(Y) PVP (Pyrrolidinovalerophenone) or 742
1104	1104	(Pyrrolidinopentiophenone). 743
1105	1105	(Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone). 744
1106	1106	(AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone). 745
1107	1107	(BB) F-MABP (Fluoromethylaminobutyrophenone). 746
1108	1108	(CC) Me-EABP (Methylethylaminobutyrophenone). 747
1109	1109	(DD) PBP (Pyrrolidinobutyrophenone). 748
1110	1110	(EE) MeO-PBP (Methoxypyrrolidinobutyrophenone). 749
1111	1111	(FF) Et-PBP (Ethylpyrrolidinobutyrophenone). 750
1112	1112
1113	1113	HB 1323 2022
1114	1114
1115	1115
1116	1116
1117	1117	CODING: Words stricken are deletions; words underlined are additions.
1118	1118	hb1323-00
1119	1119	Page 31 of 40
1120	1120	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1121	1121
1122	1122
1123	1123
1124	1124	(GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 751
1125	1125	(HH) Dimethylone (3,4 -Methylenedioxy-N,N-752
1126	1126	dimethylcathinone). 753
1127	1127	(II) 3,4-Methylenedioxy-N,N-diethylcathinone. 754
1128	1128	(JJ) 3,4-Methylenedioxy-N-acetylcathinone. 755
1129	1129	(KK) 3,4-Methylenedioxy-N-acetylmethcathinone. 756
1130	1130	(LL) 3,4-Methylenedioxy-N-acetylethcathinone. 757
1131	1131	(MM) Methylbuphedrone (Methyl -alpha-758
1132	1132	methylaminobutyrophenone). 759
1133	1133	(NN) Methyl-alpha-methylaminohexanopheno ne. 760
1134	1134	(OO) N-Ethyl-N-methylcathinone. 761
1135	1135	(PP) PHP (Pyrrolidinohexanophenone). 762
1136	1136	(QQ) PV8 (Pyrrolidinoheptanophenone). 763
1137	1137	(RR) Chloromethcathinone. 764
1138	1138	(SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone. 765
1139	1139	192. Substituted Phenethylamines. —Unless specifically 766
1140	1140	excepted or unless listed in another schedule, or contained 767
1141	1141	within a pharmaceutical product approved by the United States 768
1142	1142	Food and Drug Administration, any material, compound, mixture, 769
1143	1143	or preparation, including its salts, isomers, esters, or ethers, 770
1144	1144	and salts of isomers, esters, or ethers, whenever the existence 771
1145	1145	of such salts is possible within any of the following specific 772
1146	1146	chemical designations, any compound containing a phenethylamine 773
1147	1147	structure, without a beta-keto group, and without a benzyl group 774
1148	1148	attached to the amine group, whether or not the compound is 775
1149	1149
1150	1150	HB 1323 2022
1151	1151
1152	1152
1153	1153
1154	1154	CODING: Words stricken are deletions; words underlined are additions.
1155	1155	hb1323-00
1156	1156	Page 32 of 40
1157	1157	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1158	1158
1159	1159
1160	1160
1161	1161	further modified with or without substitution on the phenyl ring 776
1162	1162	to any extent with alkyl, alkylthio, nitro, alkoxy, thio, 777
1163	1163	halide, fused alkylenedi oxy, fused furan, fused benzofuran, 778
1164	1164	fused dihydrofuran, or fused tetrahydropyran substituents, 779
1165	1165	whether or not further substituted on a ring to any extent, with 780
1166	1166	or without substitution at the alpha or beta position by any 781
1167	1167	alkyl substituent, with or without substitution at the nitrogen 782
1168	1168	atom, and with or without inclusion of the 2 -amino nitrogen atom 783
1169	1169	in a cyclic structure, including, but not limited to: 784
1170	1170	a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 785
1171	1171	b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 786
1172	1172	c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 787
1173	1173	d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 788
1174	1174	e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 789
1175	1175	f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 790
1176	1176	g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 791
1177	1177	h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine). 792
1178	1178	i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 793
1179	1179	j. 2C-H (2,5-Dimethoxyphenethylamine). 794
1180	1180	k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 795
1181	1181	l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine ). 796
1182	1182	m. MDMA (3,4-Methylenedioxymethamphetamine). 797
1183	1183	n. MBDB (Methylbenzodioxolylbutanamine) or (3,4 -798
1184	1184	Methylenedioxy-N-methylbutanamine). 799
1185	1185	o. MDA (3,4-Methylenedioxyamphetamine). 800
1186	1186
1187	1187	HB 1323 2022
1188	1188
1189	1189
1190	1190
1191	1191	CODING: Words stricken are deletions; words underlined are additions.
1192	1192	hb1323-00
1193	1193	Page 33 of 40
1194	1194	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1195	1195
1196	1196
1197	1197
1198	1198	p. 2,5-Dimethoxyamphetamine. 801
1199	1199	q. Fluoroamphetamine. 802
1200	1200	r. Fluoromethamphetam ine. 803
1201	1201	s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 804
1202	1202	t. DOB (4-Bromo-2,5-dimethoxyamphetamine). 805
1203	1203	u. DOC (4-Chloro-2,5-dimethoxyamphetamine). 806
1204	1204	v. DOET (4-Ethyl-2,5-dimethoxyamphetamine). 807
1205	1205	w. DOI (4-Iodo-2,5-dimethoxyamphetamine). 808
1206	1206	x. DOM (4-Methyl-2,5-dimethoxyamphetamine). 809
1207	1207	y. PMA (4-Methoxyamphetamine). 810
1208	1208	z. N-Ethylamphetamine. 811
1209	1209	aa. 3,4-Methylenedioxy-N-hydroxyamphetamine. 812
1210	1210	bb. 5-Methoxy-3,4-methylenedioxyamphetamine. 813
1211	1211	cc. PMMA (4-Methoxymethamphetamine). 814
1212	1212	dd. N,N-Dimethylamphetamine. 815
1213	1213	ee. 3,4,5-Trimethoxyamphetamine. 816
1214	1214	ff. 4-APB (4-(2-Aminopropyl)benzofuran). 817
1215	1215	gg. 5-APB (5-(2-Aminopropyl)benzofuran). 818
1216	1216	hh. 6-APB (6-(2-Aminopropyl)benzofuran). 819
1217	1217	ii. 7-APB (7-(2-Aminopropyl)benzofuran). 820
1218	1218	jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran). 821
1219	1219	kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran). 822
1220	1220	ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran). 823
1221	1221	mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran). 824
1222	1222	nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran). 825
1223	1223
1224	1224	HB 1323 2022
1225	1225
1226	1226
1227	1227
1228	1228	CODING: Words stricken are deletions; words underlined are additions.
1229	1229	hb1323-00
1230	1230	Page 34 of 40
1231	1231	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1232	1232
1233	1233
1234	1234
1235	1235	oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran). 826
1236	1236	pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran). 827
1237	1237	qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran). 828
1238	1238	rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran). 829
1239	1239	ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-830
1240	1240	dihydrobenzofuran), 831
1241	1241	832
1242	1242	which does not includ e phenethylamine, mescaline as described in 833
1243	1243	subparagraph 20., substituted cathinones as described in 834
1244	1244	subparagraph 191., N -Benzyl phenethylamine compounds as 835
1245	1245	described in subparagraph 193., or methamphetamine as described 836
1246	1246	in subparagraph (2)(c)5. 837
1247	1247	193. N-Benzyl Phenethylamine Compounds. —Unless 838
1248	1248	specifically excepted or unless listed in another schedule, or 839
1249	1249	contained within a pharmaceutical product approved by the United 840
1250	1250	States Food and Drug Administration, any material, compound, 841
1251	1251	mixture, or preparation, inc luding its salts, isomers, esters, 842
1252	1252	or ethers, and salts of isomers, esters, or ethers, whenever the 843
1253	1253	existence of such salts is possible within any of the following 844
1254	1254	specific chemical designations, any compound containing a 845
1255	1255	phenethylamine structure without a beta-keto group, with 846
1256	1256	substitution on the nitrogen atom of the amino group with a 847
1257	1257	benzyl substituent, with or without substitution on the phenyl 848
1258	1258	or benzyl ring to any extent with alkyl, alkoxy, thio, 849
1259	1259	alkylthio, halide, fused alkylenedioxy, fused furan, fu sed 850
1260	1260
1261	1261	HB 1323 2022
1262	1262
1263	1263
1264	1264
1265	1265	CODING: Words stricken are deletions; words underlined are additions.
1266	1266	hb1323-00
1267	1267	Page 35 of 40
1268	1268	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1269	1269
1270	1270
1271	1271
1272	1272	benzofuran, or fused tetrahydropyran substituents, whether or 851
1273	1273	not further substituted on a ring to any extent, with or without 852
1274	1274	substitution at the alpha position by any alkyl substituent, 853
1275	1275	including, but not limited to: 854
1276	1276	a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-855
1277	1277	methoxybenzyl)]phenethylamine). 856
1278	1278	b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-857
1279	1279	hydroxybenzyl)]phenethylamine). 858
1280	1280	c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-859
1281	1281	fluorobenzyl)]phenethylamine). 860
1282	1282	d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-861
1283	1283	methylenedioxybenzyl)]phenethylamine). 862
1284	1284	e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-863
1285	1285	methoxybenzyl)]phenethylamine). 864
1286	1286	f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-865
1287	1287	hydroxybenzyl)]phenethylamine). 866
1288	1288	g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-867
1289	1289	fluorobenzyl)]phenethylamine). 868
1290	1290	h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-869
1291	1291	methylenedioxybenzyl)]phenethylamine). 870
1292	1292	i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-871
1293	1293	methoxybenzyl)]phenethylamine). 872
1294	1294	j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-873
1295	1295	methoxybenzyl)]phenethylamine). 874
1296	1296	k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-875
1297	1297
1298	1298	HB 1323 2022
1299	1299
1300	1300
1301	1301
1302	1302	CODING: Words stricken are deletions; words underlined are additions.
1303	1303	hb1323-00
1304	1304	Page 36 of 40
1305	1305	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1306	1306
1307	1307
1308	1308
1309	1309	methoxybenzyl)]phenethylamine). 876
1310	1310	l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-877
1311	1311	methoxybenzyl)]phenethylamine). 878
1312	1312	m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-879
1313	1313	hydroxybenzyl)]phene thylamine). 880
1314	1314	n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-881
1315	1315	fluorobenzyl)]phenethylamine). 882
1316	1316	o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-883
1317	1317	methylenedioxybenzyl)]phenethylamine). 884
1318	1318	p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-885
1319	1319	methoxybenzyl)]phenethylamine). 886
1320	1320	q. 25H-NBOH (2,5-Dimethoxy-[N-(2-887
1321	1321	hydroxybenzyl)]phenethylamine). 888
1322	1322	r. 25H-NBF (2,5-Dimethoxy-[N-(2-889
1323	1323	fluorobenzyl)]phenethylamine). 890
1324	1324	s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-891
1325	1325	methoxybenzyl)]phenethylamine), 892
1326	1326	893
1327	1327	which does not include substituted cathinones as described in 894
1328	1328	subparagraph 191. 895
1329	1329	194. Substituted Tryptamines. —Unless specifically excepted 896
1330	1330	or unless listed in another schedule, or contained within a 897
1331	1331	pharmaceutical product approved by the United States Food and 898
1332	1332	Drug Administration, any material, compound, mixture, or 899
1333	1333	preparation containing a 2 -(1H-indol-3-yl)ethanamine, for 900
1334	1334
1335	1335	HB 1323 2022
1336	1336
1337	1337
1338	1338
1339	1339	CODING: Words stricken are deletions; words underlined are additions.
1340	1340	hb1323-00
1341	1341	Page 37 of 40
1342	1342	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1343	1343
1344	1344
1345	1345
1346	1346	example tryptamine, structure with or without mono - or di-901
1347	1347	substitution of the amine nitrogen with alkyl or alkenyl groups, 902
1348	1348	or by inclusion of the amino nitrogen atom in a cyclic 903
1349	1349	structure, whether or not substituted at the alpha position with 904
1350	1350	an alkyl group, whether or not substituted on the indole ring to 905
1351	1351	any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy 906
1352	1352	groups, including, but not limited to: 907
1353	1353	a. Alpha-Ethyltryptamine. 908
1354	1354	b. Bufotenine. 909
1355	1355	c. DET (Diethyltryptamine). 910
1356	1356	d. DMT (Dimethyltryptamine). 911
1357	1357	e. MET (N-Methyl-N-ethyltryptamine). 912
1358	1358	f. DALT (N,N-Diallyltryptamine). 913
1359	1359	g. EiPT (N-Ethyl-N-isopropyltryptamine). 914
1360	1360	h. MiPT (N-Methyl-N-isopropyltryptamine). 915
1361	1361	i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 916
1362	1362	j. 5-Hydroxy-N-methyltryptamine. 917
1363	1363	k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 918
1364	1364	l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 919
1365	1365	m. Methyltryptamine. 920
1366	1366	n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 921
1367	1367	o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 922
1368	1368	p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 923
1369	1369	q. DiPT (N,N-Diisopropyltryptamine). 924
1370	1370	r. DPT (N,N-Dipropyltryptamine). 925
1371	1371
1372	1372	HB 1323 2022
1373	1373
1374	1374
1375	1375
1376	1376	CODING: Words stricken are deletions; words underlined are additions.
1377	1377	hb1323-00
1378	1378	Page 38 of 40
1379	1379	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1380	1380
1381	1381
1382	1382
1383	1383	s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 926
1384	1384	t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 927
1385	1385	u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine). 928
1386	1386	v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine). 929
1387	1387	w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine). 930
1388	1388	x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine). 931
1389	1389	y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-932
1390	1390	isopropyltryptamine). 933
1391	1391	z. Methyl-alpha-ethyltryptamine. 934
1392	1392	aa. Bromo-DALT (Bromo-N,N-diallyltryptamine), 935
1393	1393	936
1394	1394	which does not include tryptamine, psilocyn as described in 937
1395	1395	subparagraph 34., or psilocybin as described in subparagraph 33. 938
1396	1396	195. Substituted Phenylcyclohexylamines. —Unless 939
1397	1397	specifically excepted or unless listed in another schedule, or 940
1398	1398	contained within a pharmaceutical product approved by the United 941
1399	1399	States Food and Drug Administration, any material, compound, 942
1400	1400	mixture, or preparation containing a phenylcyclohexylamine 943
1401	1401	structure, with or without any substitution on the phenyl ring, 944
1402	1402	any substitution on the cyclohexyl ring, any replacement of the 945
1403	1403	phenyl ring with a thiophenyl or benzothiophenyl ring, with or 946
1404	1404	without substitution on the amine with alkyl, dialkyl, or alkoxy 947
1405	1405	substituents, inclusion of the nitrogen in a cyclic structure, 948
1406	1406	or any combination of the above, including, but not limited to: 949
1407	1407	a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 950
1408	1408
1409	1409	HB 1323 2022
1410	1410
1411	1411
1412	1412
1413	1413	CODING: Words stricken are deletions; words underlined are additions.
1414	1414	hb1323-00
1415	1415	Page 39 of 40
1416	1416	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1417	1417
1418	1418
1419	1419
1420	1420	(Benocyclidine). 951
1421	1421	b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog 952
1422	1422	of phencyclidine). 953
1423	1423	c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine 954
1424	1424	analog of phencyclidine). 955
1425	1425	d. PCPr (Phenylcyclohexylpropylamine). 956
1426	1426	e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene 957
1427	1427	analog of phencyclidine). 958
1428	1428	f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)). 959
1429	1429	g. PCMPA (Phenylcyclohexyl(methoxypropylamine)). 960
1430	1430	h. Methoxetamine. 961
1431	1431	i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine). 962
1432	1432	j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine). 963
1433	1433	k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine). 964
1434	1434	l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine). 965
1435	1435	m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine). 966
1436	1436	n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine). 967
1437	1437	o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine). 968
1438	1438	p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine). 969
1439	1439	q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine). 970
1440	1440	r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine). 971
1441	1441	196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-972
1442	1442	piperidinylidene]-benzenesulfonamide. 973
1443	1443	197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-974
1444	1444	piperidinylidene]-benzenesulfonamide. 975
1445	1445
1446	1446	HB 1323 2022
1447	1447
1448	1448
1449	1449
1450	1450	CODING: Words stricken are deletions; words underlined are additions.
1451	1451	hb1323-00
1452	1452	Page 40 of 40
1453	1453	F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
1454	1454
1455	1455
1456	1456
1457	1457	198. AH-7921, 3,4-dichloro-N-[[1-976
1458	1458	(dimethylamino)cyclohexyl]methyl] -benzamide. 977
1459	1459	199. U47700, trans-3,4-dichloro-N-[2-978
1460	1460	(dimethylamino)cyclohexyl]-N-methyl-benzamide. 979
1461	1461	200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine, 980
1462	1462	dihydrochloride. 981
1463	1463	Section 2. This act does not limit the authority of the 982
1464	1464	Attorney General pursuant to s. 893.035 or s. 893.0355, Florida 983
1465	1465	Statutes. 984
1466	1466	Section 3. This act shall take effect upon becoming a law. 985